Conference abstract · 28 Nov 2020
Byline
J. Blondeau
Articles whose byline reads J. Blondeau, printed most often as Joseph M Blondeau, JM Blondeau, Joseph M. Blondeau, Joseph Blondeau and J Blondeau. Different authors can share a byline.
- Articles
- 19
- Latest year
- 2020
Articles
Newest first. Showing 1–19 of 19 articles.
Conference abstract · 18 Sep 2020
Diagnostic Clinical Microbiology Laboratories and COVID-19: Are we really prepared?
Short communication · 29 Jul 2020
Future Microbiology 2020 Diagnostic Clinical Microbiology Laboratories and COVID-19
Conference abstract · 12 Dec 2019
Euro Clinical Microbiology2019: What have we learned from in vitro antimicrobial susceptibility/resistance and time kill measurements and how does such data influence clinical use?-JM Blondeau-Royal University
Short communication · 27 Apr 2017
Euro Clinical Microbiology2019: What have we learned from in vitro antimicrobial susceptibility/resistance and time kill measurements and how does such data influence clinical use?
Research article · 1 Feb 2017
Application of the Formula for Rational Antimicrobial Therapy (FRAT) to Community-Acquired Pneumonia
Other · 5 Aug 2016
Management of community-acquired lower respiratory tract infections: gemifloxacin; a new economic paradigm
Review article · 27 Jul 2016
Update on the use of the macrolides for community-acquired respiratory tract infections
Other · 27 Jul 2016
Antibiotic resistance: what have we learned and where do we go from here?
Other · 26 Jul 2016
Tigecycline: an overview and update
Short communication · 26 Jul 2016
The mutant prevention concentration as a strategy to minimize antimicrobial resistance- a timely concept but will it\'s acceptance be too late?
Review article · 15 Jul 2016
Judicious use of antibiotics to minimize emerging resistance: the macrolide clarithromycin as a case study
Commentary · Nov 2013
Journal Watch (Interivew)
Editorial · Jan 2013
Do we really understand what we want or need out of antimicrobial stewardship programs?
Editorial · Jul 2012
Advances in laboratory diagnostic technologies in clinical microbiology and what this means for clinical practice
Editorial · Nov 2005
Differential impact of macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae
Editorial · Jul 2005
Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs?
Conference abstract
What have we learned from in vitro antimicrobial susceptibility/resistance and time kill measurements and how does such data influence clinical use?
Conference abstract

